Multiples.
Renuka Ramnath's $1.8bn platform executing India's liquidity-engineering playbook at PE scale: a $430M oversubscribed continuation fund (Vastu, Quantiphi, APAC), ~$244M of Vastu secondaries at $1.4bn, and a decisive 2025 pivot to control: QBurst (~$200M) and listed VIP Industries (₹1,408 Cr).
GW GP Score
Multiples is Indian PE's continuation-vehicle pioneer meeting its control-deal era. The May 2025 CV (HarbourVest/Hamilton Lane/LGT/TPG NewQuest-led, oversubscribed) gave Fund II LPs full liquidity on three assets while the firm kept compounding them; the 2024 Vastu secondaries (~$244M to TA, Prosus, Faering at $1.4bn) showed the same instinct. Deployment has turned to control: QBurst with acquisition debt from HSBC/Nomura, VIP Industries' promoter stake with an open offer, plus a new private-credit vertical under an ex-Deutsche sponsor-finance head. The soft spots: Fund IV closed ~$800M against a $1bn ambition, and the venture-era book (Licious, Acko, MoEngage, Niyo) awaits its windows.
Re-up candidate: the realised-cash evidence is doing more work than the brand story.
Portfolio quality depends on a narrow theme; the right comp is concentration risk, not headline unicorn count.
No named analyst override yet; current view is generated from the scored dossier and should be refreshed when the next primary source lands.
Zenex sale process (launched Aug 2025): unresolved.
Fund IV final size (~$800M single-sourced): never firm-confirmed.
CVs defer rather than prove: if Vastu/Quantiphi exits disappoint, the 2025 liquidity round reprices retroactively.
Computed from current dossier sources; analyst override pending.
India's continuation-vehicle pioneer pivoting to control: sophisticated capital management with an evidence gap where clean exits would be. Stable, with the CV assets' eventual realisations as the proof pending.
Vastu at $1.4bn, VIP/QBurst control platforms, four unicorn-class holds
~$674M of engineered Fund II liquidity + historical 6x Delhivery/Dream11 prints
FS depth + control pivot + credit vertical; green-economy talk still thin
CV closed fast; Fund IV short of ambition; credit fund unclosed
Founder-led 17 years, deep MD bench, no visible churn
Portfolio quality 25% · Exit realisation 30% · Sector positioning 15% · Capital velocity 15% · Franchise stability 15%: see the full GP Score methodology · compare this firm →
Positive catalysts and/or re-up evidence exceed the visible risks, but the score should move only after the named proof lands.
Vastu Housing Finance liquidity clears with credible OFS/block-sale evidence.
Fund IV final size (~$800M single-sourced): never firm-confirmed.
Zenex sale process (launched Aug 2025): unresolved.
The CV is the diligence object: oversubscription by HarbourVest/Hamilton Lane/LGT is real validation, but ask what Fund II's DPI would have been WITHOUT the engineered liquidity. Roll-or-sell optionality favoured informed insiders.
CVs defer rather than prove: if Vastu/Quantiphi exits disappoint, the 2025 liquidity round reprices retroactively.
Zenex sale process (launched Aug 2025): unresolved.
Coverage initiated: inaugural GW GP Score.
Catalyst exposure · latest source pressure
Recent public evidence mapped to this GP. Read this before reading the position table: it is where the score can move next.
Keep the file warm; current events cut both ways or are not yet material enough to move score.
Attribution0 positive catalyst(s), 0 pressure catalyst(s); top driver: monthly refresh only.
The funds
$1.8bn AUM · ~$3bn raised incl. CV across 4 tracked vehicles.
| Vehicle | Vintage | Size | Stage | Note |
|---|---|---|---|---|
| Continuation Fund | 2025Recovery / IPO window | $430M | CV: Fund II assets | Vastu, Quantiphi, APAC Financial; HarbourVest/Hamilton Lane/LGT/TPG NewQuest led; UBS advised |
| Fund IV (+ GIFT Fund IV) | 2023-24Trough window | ~$800M (E) | Growth/control | First close $640M; CPPIB, IFC, SBI among LPs; short of $1bn hard-cap ambition |
| Fund III | 2021Peak frenzy | $685M | Growth | vs $750M target |
| Funds I-II | 2011 / 2017Foundation era | $405M / $690M | Growth | Fund II residuals rolled into the CV |
Closest booksPrime Venture Partners (1 shared) · A91 Partners (1 shared) · Z47 (1 shared)computed · E
Fund analytics · LP underwriting screen
Computed from the public dossier: vehicle cadence, realised exits, mark drift, concentration and franchise stability. All computed signals are GW estimates.
Latest vehicle closed inside the current exit/repricing window.
Next liquidityVastu Housing Finance · Quantiphi · Licious · MoEngage · Niyo
2 visible exit events since Jul 2024.
Latest vehicle closed inside the current exit/repricing window.
8 up / 4 flat / 0 down tracked signals.
No senior departure flagged in key people.
8 up / 4 flat / 0 down
2 events since Jul 2024
Largest tracked active exposure
Higher spread = less balanced franchise
Exit-led repricing; entry discipline decisive
Best entry conditions of the cycle
Cycle-top entry marks; the vintage still being digested
Pre-unicorn pricing; discovery-cost entries
$1.4bn mark via 2024 secondaries; now held via the CV; Prosus bought $100M of it
AI services; rolled into CV
IPO deferred to FY27-28 at ~$2bn ambition; co-held with 3one4
Fourth tracked holder
Third tracked holder
SEBI-approved ₹2,800 Cr IPO; Multiples not in the OFS list
Latest cited source appears to be 2025.
2 visible events tracked.
12 representative positions tracked.
No departure signal structured.
Fund-level DPI/TVPI is usually not public; proxy remains estimated.
Peer median 4 · -1
Peer median 4 · +2
Peer median 91 · -13
Peer median 66 · +2
Peer median 0 · +0
Diligence agenda · how this view can change
The live research question, the proof required, and the source standard. This prevents a GP score from becoming a stale label.
Performance proxy evidence remains low-confidence despite a scored dossier.
Recent · Latest cited source appears to be 2025.
Upgrade the weak fields with dated facts before the next score action: Performance proxy.
Prioritise filings and firm disclosures; mark estimates as GW E until then.
Fund IV final size (~$800M single-sourced): never firm-confirmed.
Vastu Housing Finance: next public-market or secondary print
Evidence quality · source file health
How hard the public record is beneath this view: source mix, freshness, low-confidence fields and the next source action.
Low-confidence fields: Performance proxy.
5 total sources · 20% primary
Latest cited source appears to be 2025.
Multiples: Continuation Fund press release (May 2025)
Upgrade Performance proxy evidence before changing the score.
Source tiering follows Gravitywell policy: primary = filing/regulator/company disclosure, secondary = reputable media or research, E = Gravitywell estimate. Evidence score is a GW control metric, not an external rating.
The position book
35 enterprises backed. 12 tracked below.
| Company | Sector | Entered | Entry stage | Status | 12-mo signal | Latest read |
|---|---|---|---|---|---|---|
| Vastu Housing Finance | Fintech | 2016 | Growth | Soonicorn | ▲ | $1.4bn mark via 2024 secondaries; now held via the CV; Prosus bought $100M of it |
| Quantiphi | AI | 2019 | Growth | Soonicorn | ▲ | AI services; rolled into CV |
| APAC Financial | Fintech | 2018 | Growth | Private | → | Rolled into CV |
| VIP Industries | Consumer & Commerce | 2025 | Listed control (25.55%) | Public | ▲ | Promoter purchase + open offer at ₹388: the listed-buyout playbook |
| QBurst | SaaS & Dev Tools | 2025 | Control (~$200M) | Private | ▲ | HSBC + Nomura ₹500 Cr acquisition debt; new CEO installed |
| Licious | Consumer & Commerce | 2021 | Series F co-led ($192M w/ Temasek) | Unicorn | → | IPO deferred to FY27-28 at ~$2bn ambition; co-held with 3one4 |
| Acko | Fintech | 2022 | Growth | Unicorn | → | Third tracked holder (Elevation, Lightspeed) |
| MoEngage | SaaS & Dev Tools | 2021 | Growth | Soonicorn | ▲ | Fourth tracked holder |
| Niyo | Fintech | 2022 | Growth | Soonicorn | → | Third tracked holder |
| Zenex Animal Health | Healthcare | 2021 | Buyout consortium (w/ CPPIB) | Private | ▲ | Sale process launched Aug 2025: partial/full exit sought; unresolved |
| Veritas Finance | Fintech | 2023 | ₹1,050 Cr of ₹1,200 Cr round | Private | ▲ | SEBI-approved ₹2,800 Cr IPO; Multiples not in the OFS list |
| TI Clean Mobility | EV & Climate | 2023 | Up to ₹1,200 Cr committed | Private | ▲ | Murugappa EV platform |
Representative tracked positions reconstructed from public disclosures: not the full book. 12-mo signal is a GW estimate of mark direction from round/exit prints (E). Ownership stakes are not shown: not reliably public.
Sector exposure · where the book leans
Share of the tracked active book by normalized sector (GW estimate): read against our sector dossiers for crowding.
New cheques · 2025-26
The 2024-25 sequence is a deliberate escalation: minority growth (Svatantra, Shubham) → control services (QBurst, with acquisition leverage) → listed control (VIP with an open offer). Financial services absorbs the largest share of capital; the credit vertical hire signals structured products next. No new platform deal in H1 2026: digestion phase.
Completed; control changed
Largest tech-services control deal for the firm
Largest Indian MFI PE deal
Realisation · are LPs getting paid?
Liquidity engineering at PE scale: ~$674M of Fund II monetisation across secondaries and the CV without waiting for IPO windows. The style choice is explicit: sell to later capital, keep managing the assets. Historical prints (Delhivery ~6x to Tiger, Dream11 partials at $5bn) anchor the venture-era record; the CV keeps the newer marks in-house.
$430M CV on Vastu/Quantiphi/APAC: full-liquidity option for Fund II LPs; oversubscribed; among India's largest PE secondaries.
~$244M sold across TA ($150M), Prosus ($100M at $1.4bn), Faering: Fund II monetisation before the CV.
HarbourVest/Hamilton Lane/LGT/TPG NewQuest: the secondaries establishment underwrote the book
Externally set by Prosus's $100M secondary purchase
Single-source final figure; short of ambition
No fund-level numbers public
No DPI published, but the CV's oversubscription is third-party underwriting of the residual book, and Prosus set Vastu's mark with real money. GW read: sophisticated liquidity management partially substituting for traditional exits: LPs got optionality; observers get less proof than a clean sale would provide. E.
What they're doing
Liquidity engineering as franchise skill: secondaries → CV → (next) credit products; LPs choose their duration.
Escalate to control: QBurst and VIP mark the shift from growth minority to leveraged/listed buyouts.
Financial-services concentration as conviction: Svatantra, Shubham, Vastu, Veritas, APAC, Kogta.
Private-credit vertical (Chawla) + GIFT City vehicle broaden the platform beyond fund PE.
What can break
CVs defer rather than prove: if Vastu/Quantiphi exits disappoint, the 2025 liquidity round reprices retroactively.
Control deals with acquisition debt (QBurst) import leverage-execution risk new to the franchise.
Venture-era positions (Licious, Acko, Niyo) depend on IPO windows the firm doesn't control; Licious already slipped to FY27-28.
Fund IV's shortfall constrains the control ambition it was raised to fund.
Zenex sale process (launched Aug 2025): unresolved.
Fund IV final size (~$800M single-sourced): never firm-confirmed.
Credit vertical's first fund close.
Licious IPO slippage (FY27-28).
Point-in-time discipline: these are the open items we could not verify at the current vintage. They get resolved: confirmed, corrected or dropped, at the next monthly refresh, never silently.
The takes · one screen, three readers
The CV is the diligence object: oversubscription by HarbourVest/Hamilton Lane/LGT is real validation, but ask what Fund II's DPI would have been WITHOUT the engineered liquidity. Roll-or-sell optionality favoured informed insiders.
Multiples proved Indian assets can clear institutional secondaries at scale: your Fund II problem now has a template. Its control pivot also means it bids against buyout shops, not just growth funds.
VIP Industries is the case study: PE buying listed Indian consumer control from exiting promoters at open-offer discipline. If it works, a repricing wave for promoter-heavy midcaps follows.
Sourcing. Every figure is sourced and dated. We tier provenance: Primary (official, regulatory, exchange or company filings), Secondary (tier-1 industry research and reputable media), and GW estimate (our own reconstruction or opinion, labelled, never presented as external fact). We prefer primary where it exists, reconcile divergent prints to cited ranges, and hold every number point-in-time: dated, and never silently restated; revisions publish as dated changes.
Fact vs opinion. Facts vs opinion: market sizes, official prints, prices, named deals and agency ratings are sourced facts (Primary/Secondary). Scores, grades, purity weights, scenario paths and indicative sparkline points are Gravitywell's analytical opinion (GW estimate): labelled, not presented as external data.
GW GP Scores are research opinions, not investment advice, not a solicitation, and not an assessment under any SEBI regulation. Dossiers are compiled from public sources believed reliable; firms named did not participate and figures marked E are Gravitywell estimates. Point-in-time: dated to the vintage shown and never silently restated.